Research summary of early stage breast cancer in young women
10.3760/cma.j.cn115396-20200221-00036
- VernacularTitle:年轻女性早期乳腺癌的研究概况
- Author:
Naichang XIE
1
Author Information
1. 广西医科大学第一附属医院胃肠腺体外科，南宁 530021
- From:
International Journal of Surgery
2020;47(5):356-360
- CountryChina
- Language:Chinese
-
Abstract:
Breast cancer in young women has low early diagnosis rate, high malignancy degree, poor prognosis, and patients have a strong desire to breast conserving. Therefore, it has become a research topic of widespread. To discuss the disease characteristics and rational treatment for breast cancer in young women (BCYW), use PubMed search engine to seek the document literature in BCYW aged under 40 years old over past 10 years. And the latest research achievement in adjuvant systemic therapy of young women less than 40 years of age with early invasive breast cancer has been published by several important multicenter prospective randomized controlled trials, including the Trial Assigning Individualized Options for Treatment, the Suppression of Ovarian Function trial and the Tamoxifen and Exemestane trial. In the meantime, to review the international consensus guidelines for BCYW founded by the European School of Oncology and the European Society of Medical Oncology, the clinical practice guidelines of National Comprehensive Cancer Network and American Society of Clinical Oncology for breast cancer, and the newest update in these guidelines.
